Microfluidic-assisted preparation of PLGA nanoparticles for drug delivery purposes: experimental study and computational fluid dynamic simulation.
Computational fluid dynamic
Microfluidics
Nanoparticles
Nanoprecipitation
Polylactic-coglycolicacid
Journal
Research in pharmaceutical sciences
ISSN: 1735-5362
Titre abrégé: Res Pharm Sci
Pays: Iran
ID NLM: 101516968
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
5
12
2019
Statut:
epublish
Résumé
This study, for the first time, tries to provide a simultaneous experimental and computational fluid dynamic (CFD) simulation investigation for production of uniform, reproducible, and stable polylactic-co-glycolic acid (PLGA) nanoparticles. CFD simulation was carried out to observe fluid flow behavior and micromixing in microfluidic system and improve our understanding about the governing fluid profile. The major objective of such effort was to provide a carrier for controlled and sustained release profile of different drugs. Different experimental parameters were optimized to obtain PLGA nanoparticles with proper size and minimized polydispersity index. The particle size, polydispersity, morphology, and stability of nanoparticles were compared. Microfluidic system provided a platform to control over the characteristics of nanoparticles. Using microfluidic system, the obtained particles were more uniform and harmonious in size, more stable, monodisperse and spherical, while particles produced by batch method were non-spherical and polydisperse. The best size and polydispersity index in the microfluidic method was obtained using 2% PLGA and 0.0625% (w/v) polyvinyl alcohol (PVA) solutions, and the flow rate ratio of 10:0.6 for PVA and PLGA solutions. CFD simulation demonstrated the high mixing intensity of about 0.99 at optimum condition in the microfluidic system, which is the possible reason for advantageous performance of this system. Altogether, the results of microfluidic-assisted method were found to be more reproducible, predictable, and controllable than batch method for producing a nanoformulation for delivery of drugs.
Identifiants
pubmed: 31798663
doi: 10.4103/1735-5362.268207
pii: RPS-14-459
pmc: PMC6827194
doi:
Types de publication
Journal Article
Langues
eng
Pagination
459-470Informations de copyright
Copyright: © 2019 Research in Pharmaceutical Sciences.
Références
Langmuir. 2004 Sep 28;20(20):8604-11
pubmed: 15379481
Lab Chip. 2009 Oct 21;9(20):3007-11
pubmed: 19789758
Drug Dev Ind Pharm. 2018 Feb;44(2):199-205
pubmed: 28956466
Langmuir. 2009 Feb 17;25(4):1970-9
pubmed: 19170510
Int J Pharm. 2005 May 13;295(1-2):269-81
pubmed: 15848011
Res Pharm Sci. 2013 Oct;8(4):219-31
pubmed: 24082891
J Pharm Pharmacol. 2004 Jul;56(7):827-40
pubmed: 15233860
Int J Pharm. 2009 Jun 22;375(1-2):107-13
pubmed: 19481696
Res Pharm Sci. 2014 Nov-Dec;9(6):407-20
pubmed: 26339256
Res Pharm Sci. 2017 Jun;12(3):222-232
pubmed: 28626480
Res Pharm Sci. 2015 Mar-Apr;10(2):95-108
pubmed: 26487886
J Colloid Interface Sci. 2008 Jun 15;322(2):505-15
pubmed: 18402975
Adv Drug Deliv Rev. 2013 Nov;65(11-12):1420-46
pubmed: 23770061
Eur J Pharm Sci. 2010 Oct 9;41(2):244-53
pubmed: 20600881
Res Pharm Sci. 2017 Feb;12(1):1-14
pubmed: 28255308
J Biomed Mater Res B Appl Biomater. 2003 Aug 15;66(2):559-66
pubmed: 12861608